DeepMed Research

ASSAF HAROFEH MEDICAL CENTER

🇮🇱Israel

Country: 🇮🇱Israel

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.assafh.org

Clinical Trials

Predictive Factors for Successful Operative Hysteroscopy Using Tissue Removal Device (TruClear System) Without Anesthesia

Recruiting

Conditions: Uterine Polyp
Retained Products of Conception

Interventions: Procedure: hysteroscopy

First Posted Date: 2023-02-10

Last Posted Date: 2023-02-10

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 70

Registration Number: NCT05722028

Locations: 🇮🇱
Shamir medical center, Zrifin, Israel

Tranexamic Acid During Upper GI Endoscopic Resection Procedures

Phase 4

Recruiting

Conditions: Gastric Polyp
Gastric Neoplasm
Duodenal Neoplasms
Esophageal Neoplasms

Interventions: Drug: Epinephrine injection
Drug: Tranexamic acid

First Posted Date: 2023-01-18

Last Posted Date: 2023-08-09

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 200

Registration Number: NCT05688020

Locations: 🇮🇱
Shamir Medical Center, Be'er Ya'aqov, Israel

Colchicine and Inflammation in Hemodialysis Patients

Phase 2

Recruiting

Conditions: End Stage Renal Disease on Dialysis

Interventions: Drug: Colchicine 0.5 MG
Drug: Placebo

First Posted Date: 2023-01-10

Last Posted Date: 2023-01-10

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 50

Registration Number: NCT05677555

Locations: 🇮🇱
Asaf ha Rofeh, MC, Zrifin, Israel

Cesarean Scar Evaluation Using Saline Infusion Sonography in Women With Previous Pregnancy in Scar

Not Applicable

Not yet recruiting

Conditions: Uterus; Scar

Interventions: Drug: Saline infusion sonography for evaluation of cesarean scar

First Posted Date: 2023-01-05

Last Posted Date: 2023-01-05

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 40

Registration Number: NCT05672563

Medical vs Surgical Treatment in OSA Among Children

Phase 4

Conditions: To Determine Clinical Response to Montelukast or Nasal Steroids Based on PSQ Results
To Evaluate PSQ as Clinical Tool in the Decision Between Medical and Surgical Treatment for Adenotonsillar Hypertrophy

Interventions: Drug: Fluticasone Furoate
Drug: Montelukast

First Posted Date: 2022-12-15

Last Posted Date: 2022-12-15

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 90

Registration Number: NCT05651750

Locations: 🇮🇱
Assaf-Harofeh Medical Center, Be'er Ya'aqov, Israel

Ultrasound Guided Fallopian Tube Catheterization During Hysterosalpingo-foam Sonography (HyFoSy)

Not Applicable

Conditions: Fallopian Obstruction Tube

Interventions: Procedure: Ultrasound guided transcervical fallopian tube catheterization during hysterosalpingo-foam sonography in the treatment of proximal tubal obstruction

First Posted Date: 2022-09-13

Last Posted Date: 2022-09-13

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 30

Registration Number: NCT05537805

The Impact of Bedside Wipes in Multi-patient Rooms: a Prospective, Crossover Trial Evaluating Infections and Survival

Not Applicable

Completed

Conditions: Hospital Acquired Infection

Interventions: Other: Single-use wipes installed at the bedside

First Posted Date: 2022-08-31

Last Posted Date: 2022-09-02

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 7725

Registration Number: NCT05522725

Locations: 🇮🇱
Shamir Medical Center (Assaf Harofeh), Be'er Ya'aqov, Israel

Anal Manometry Examination in Patients With Ulcerative Colitis

Not Applicable

Conditions: Ulcerative Colitis

Interventions: Procedure: Performing anorectal manometry

First Posted Date: 2022-08-04

Last Posted Date: 2022-08-04

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 150

Registration Number: NCT05488041

Locations: 🇮🇱
Shamir Medical Center (Assaf Harofeh), Zerifin, Israel

Quantum Molecular Resonance Effects on Patients With Dry Eye Disease

Not Applicable

Conditions: Dry Eye Syndromes

Interventions: Device: Rexon device

First Posted Date: 2022-07-22

Last Posted Date: 2022-07-22

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 50

Registration Number: NCT05469932

Locations: 🇮🇱
Shamir Medical Center, Tel Aviv, Israel

Intermittent Hypoxic Training (IHT) Versus Hyperbaric Oxygen Therapy (HBOT) for Aerobic Performance

Not Applicable

Recruiting

Conditions: Healthy Active Athletes

Interventions: Device: Intermittent Hypoxic Training - IHT
Device: Hyperbaric Oxygen Therapy - HBOT

First Posted Date: 2022-07-07

Last Posted Date: 2024-07-03

Lead Sponsor: Assaf-Harofeh Medical Center

Target Recruit Count: 66

Registration Number: NCT05447416

Locations: 🇮🇱
The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh), Zrifin, Israel

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy